申请人:Wyeth
公开号:US20030153599A1
公开(公告)日:2003-08-14
The present invention provides a compound of formula I and the use thereof for the therapeutic treatment of disorders relating to or affected by the 5-HT6 receptor.
1
本发明提供了一种I式化合物及其用途,用于治疗与或受5-HT6受体相关的疾病。